Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects. [Phase 2]
A Phase 2 trial evaluating electrochemotherapy for chest wall recurrence of breast cancer was terminated, with results posted in 2014 discus…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: First Line Therapy for Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial update for first-line therapy in metastatic breast cancer has terminated; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) [Phase 3]
Phase 3 study comparing ETC versus EC-TX regimens and Ibandronate versus observation in node-positive primary breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Study in Elderly Patients With Early Breast Cancer (ICE) [Phase 3]
A Phase 3 clinical trial in elderly patients with early breast cancer (ICE) has completed recruitment and status is reported as completed.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer [Phase 2]
A Phase 2 trial comparing anastrozole plus placebo to anastrozole plus gefitinib (ZD1839) in postmenopausal patients with ER/PR-positive met…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and nab-paclitaxel with or without vorinostat in newly diagnosed operable breast cancer; results were p…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer [Phase 2]
A Phase 2 clinical trial assessed the safety and leukostimulatory activity of Panagen in patients with breast cancer; results have been post…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer
Update on a clinical trial evaluating gemcitabine as a single-agent maintenance chemotherapy for patients with metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy. [Phase 1, Phase 2]
This update reports the completion of a Phase 1/Phase 2 clinical trial evaluating an exercise intervention for patients with early-stage bre…
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. [Phase 1]
Phase 1 trial assessing the safety and tolerability of AZD8931 alone or with paclitaxel in Japanese patients with breast cancer and other me…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation [NA]
This clinical trial compared MRI and Molecular Breast Imaging for breast diagnostic evaluation. The study is completed and results were post…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Biological Therapy in Treating Patients With Advanced Cancer [NA]
This clinical trial update reports a completed study of a biological therapy in patients with advanced cancer, including breast, gastric, an…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors [NA]
Tamoxifen was studied in a completed clinical trial to prevent breast cancer in survivors of Hodgkin's disease. The study was sponsored by D…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer [Phase 1]
Phase 1 trial evaluating the safety of weekly paclitaxel in combination with neratinib and trastuzumab in metastatic HER2-positive breast ca…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial [Phase 3]
A Phase 3 trial evaluating simultaneous gemcitabine-docetaxel adjuvant therapy with extended bisphosphonate and surveillance for breast canc…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy [Phase 4]
Phase 4 trial assessing the effect of a bisphosphonate on bone loss in postmenopausal women with breast cancer initiating aromatase inhibito…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Effect of Metformin on Breast Cancer Metabolism [Phase 2]
A Phase 2 clinical trial investigating metformin's effect on breast cancer metabolism has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors [Phase 1]
A completed Phase 1 trial evaluating the safety and dosing of the lapatinib and paclitaxel combination in patients with advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 [Phase 1]
A Phase 1 study evaluating lapatinib for advanced or metastatic HER2-overexpressing breast cancer has been completed. The trial was sponsore…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer [EARLY_Phase 1]
This early-phase 1 trial evaluated whether AZD6244 (selumetinib) can increase estrogen receptor expression and enhance anti-estrogen respons…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine [Phase 2]
An open-label, randomized Phase II study evaluating Indisulam in combination with capecitabine for metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery [NA]
Clinical trial update for MarginProbe, a device used to assess margins during breast-conserving surgery; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer [Phase 2]
Phase 2 study evaluating bevacizumab (Avastin) with taxane-based chemotherapy as first-line treatment for HER2-negative breast cancer; resul…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab emtansine (T-DM1) sequenced with anthracycline-based chemotherapy as adjuvant or neoadjuvant therapy fo…
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease [Phase 2]
Update on a Phase 2 trial of BAY88-8223 (Alpharadin) in breast cancer patients with bone-dominant disease; the study has completed.